Amobarbital
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral, IM, IV, Rectal |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Elimination half-life | 8-42 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C11H18N2O3 |
| Molar mass | 226.272 |
|
WikiDoc Resources for Amobarbital |
|
Articles |
|---|
|
Most recent articles on Amobarbital Most cited articles on Amobarbital |
|
Media |
|
Powerpoint slides on Amobarbital |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Amobarbital at Clinical Trials.gov Clinical Trials on Amobarbital at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Amobarbital
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Amobarbital Discussion groups on Amobarbital Patient Handouts on Amobarbital Directions to Hospitals Treating Amobarbital Risk calculators and risk factors for Amobarbital
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Amobarbital |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Amobarbital (formerly known as amylobarbitone) is a drug that is a barbiturate derivative. It has sedative-hypnotic and analgesic properties. It is a white crystalline powder with no odor and a slightly bitter taste. If amobarbital is taken for extended periods of time, physical and psychological dependence can develop.
Pharmacology
According to an in vitro study conducted at the University of British Columbia, amobarbital works by activating GABAA receptors, which decreases input resistance, depresses burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increases both the amplitude and decay time of postsynaptic currents.[1]
It has an LD50 in mice of 212 mg/kg s.c.
Metabolism
Amobarbital undergoes both hydroxylation to form 3'-hydroxyamobarbital,[2] which has both levorotatory and dextrorotatory isomers[3] and N-glucosidation[4] to form 1-(beta-D-glucopyranosyl)amobarbital.[5]
Indications
Approved
Unapproved/Off-Label
- Sodium amobarbital has a reputation for having activity as a truth serum, where the person under the influence of the drug will submit to almost any request given by another person. It has been used to convict murderers such as Andres English-Howard, who strangled his girlfriend to death but claimed innocence. He was surreptitiously administered the drug, by his attorney, and under the influence of it he revealed why he strangled her and under which circumstances. A year later he confessed, on the stand, and was convicted on the basis of these statements; he later committed suicide in his cell.[6] The use of amobarbital as a truth serum has lost credibility due to the discovery that the subject can be coerced into having a 'false memory' of the event. In controlled doses, it is used in the Narco Analysis test to trace crime and criminals in modern forensics.
- Catatonic mutism, sometimes combined with caffeine to combat somnolence.[7]
- It was also used in the Battle of the Bulge as a healing pill to send people back to the front.[8]
Contraindications
The following drugs should be avoided when taking amobarbital:
- Alcohol
- Caffeine
- Chloramphenicol
- Chlorpromazine
- Cyclophosphamide
- Ciclosporin
- Digitoxin
- Doxorubicin
- Doxycycline
- Methoxyflurane
- Metronidazole
- Quinine
- Theophylline
- Warfarin
- Benzodiazepines, such as diazepam, clonazepam or nitrazepam
- Antiepileptics, such as phenobarbital or carbamazepine
- Antihistamines, such as doxylamine and clemastine
- Narcotic analgesics, such as morphine and oxycodone
- Steroids, such as prednisone and cortisone
- Antidepressants
- Antihypertensives, such as atenolol and propranolol
- Antiarrhythmics, such as verapamil and digoxin
Amobarbital has been known to decrease the effects of hormonal birth control, sometimes to the point of uselessness. Being chemically related to phenobarbital, it might also do the same thing to digitoxin, a cardiac glycoside.
In 1988, Miller et al reported that amobarbital increases benzodiazepine receptor binding in vivo with less potency than secobarbital and pentobarbital (in descending order), but greater than phenobarbital and barbital (in ascending order).[9]
Overdose
Some side effects of overdose include confusion (severe); decrease in or loss of reflexes; drowsiness (severe); fever; irritability (continuing); low body temperature; poor judgment; shortness of breath or slow or troubled breathing; slow heartbeat; slurred speech; staggering; trouble in sleeping; unusual movements of the eyes; weakness (severe). Death can be a result.
See also
References and End Notes
- ↑ Kim HS, Wan X, Mathers DA, Puil E. "Selective GABA-receptor actions of amobarbital on thalamic neurons." British Journal of Pharmacology. 2004 Oct;143(4):485-94. Epub 2004 Sep 20. PMID 15381635
- ↑ Maynert EW. "The alcoholic metabolites of pentobarbital and amobarbital in man." Journal of Pharmacology and Experimental Therapeutics. 1965 Oct;150(1):118-21. PMID 5855308
- ↑ Chemicals: 3'-hydroxyamobarbital The Comparative Toxicology Database.
- ↑ Tang BK, Kalow W, Grey AA. "Amobarbital metabolism in man: N-glucoside formation." Research Communications in Chemical Pathology and Pharmacology. 1978 Jul;21(1):45-53. PMID 684279
- ↑ Soine PJ, Soine WH. "High-performance liquid chromatographic determination of the diastereomers of 1-(beta-D-glucopyranosyl)amobarbital in urine." Journal of Chromatography. 1987 Nov 27;422:309-14. PMID 3437019
- ↑ Truth Serum: A Possible Weapon, 60 Minutes, April 23, 2003.
- ↑ McCall WV. "The addition of intravenous caffeine during an amobarbital interview." Journal of Psychiatry & Neuroscience. 1992 Nov;17(5):195-7. PMID 1489761
- ↑ Use of sodium amytal during WWII
- ↑ Miller LG, Deutsch SI, Greenblatt DJ, Paul SM, Shader RI (1988). "Acute barbiturate administration increases benzodiazepine receptor binding in vivo". Psychopharmacology (Berl). 96 (3): 385–90. PMID 2906155
- Controlled Substances in Schedule II Office of Diversion Control, Drug Enforcement Administration.
- Controlled Substances in Schedule III Office of Diversion Control, Drug Enforcement Administration.
External links
Template:SIB de:Amobarbital gl:Amobarbital sl:Amobarbiton fi:Amobarbitaali sv:Amobarbital
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs